Malnutrition is common in liver cirrhotic patients who will undergo liver resection or liver transplantation. A precise evaluation of their nutrition status is thus difficult because of the presence of ascites and the edema caused by their impaired protein synthesis. Both perioperative enteral and parenteral nutrition have benefits in reducing the morbidity and mortality of liver surgery, and in general, oral nutrition supplements are recommended. Branched-chain amino acids (BCAAs) promote protein and glycogen synthesis and regulate immune system function. Synbiotics, a combination of pro- and prebiotics, is reported to enhance immune responses. Oral nutrition support with BCAAs, synbiotics, and an immune-enhancing diet have a beneficial effect on preventing the perioperative infections associated with hepatic resection or liver transplantation.
O’BrienAWilliamsR. Nutrition in end-stage liver disease: principles and practice. Gastroenterology. 2008;134(6):1729-1740.
2.
AlberinoFGattaAAmodioP. Nutrition and survival in patients with liver cirrhosis. Nutrition. 2001;17(6):445-450.
3.
CaregaroLAlberinoFAmodioP. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr. 1996;63(4):602-609.
4.
CordobaJLopez-HellinJPlanasM. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol. 2004;41(1):38-43.
5.
DonaghyA. Issues of malnutrition and bone disease in patients with cirrhosis. J Gastroenterol Hepatol. 2002;17(4):462-466.
6.
HenkelASBuchmanAL. Nutritional support in patients with chronic liver disease. Nat Clin Pract Gastroenterol Hepatol. 2006;3(4):202-209.
7.
TsiaousiETHatzitoliosAITrygonisSKSavopoulosCG. Malnutrition in end stage liver disease: recommendations and nutritional support. J Gastroenterol Hepatol. 2008;23(4):527-533.
8.
MerliMNicoliniGAngeloniSRiggioO. Malnutrition is a risk factor in cirrhotic patients undergoing surgery. Nutrition. 2002;18(11-12):978-986.
9.
PikulJSharpeMDLowndesRGhentCN. Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation. 1994;57(3):469-472.
10.
RicciPTherneauTMMalinchocM. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology. 1997;25(3):672-677.
11.
SelbergOBottcherJTuschGPichlmayrRHenkelEMullerMJ. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology. 1997;25(3):652-657.
12.
FigueiredoFDicksonERPashaT. Impact of nutritional status on outcomes after liver transplantation. Transplantation. 2000;70(9):1347-1352.
13.
ShahidMJohnsonJNightingalePNeubergerJ. Nutritional markers in liver allograft recipients. Transplantation. 2005;79(3):359-362.
14.
CalderPC. Branched-chain amino acids and immunity. J Nutr. 2006;136(1)(suppl):288S-293S.
15.
ChoudryHAPanMKarinchAMSoubaWW. Branched-chain amino acid-enriched nutritional support in surgical and cancer patients. J Nutr. 2006;136(1)(suppl):314S-318S.
16.
CharltonM. Branched-chain amino acid enriched supplements as therapy for liver disease. J Nutr. 2006;136(1)(suppl):295S-298S.
17.
HolecekM. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition. 2010;26(5):482-490.
18.
RazonableRRFindlayJYO’RiordanA. Critical care issues in patients after liver transplantation. Liver Transpl. 2011;17(5):511-527.
19.
MerliMGiustoMGentiliF. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int. 2010;30(2):208-214.
20.
HarrisonJMcKiernanJNeubergerJM. A prospective study on the effect of recipient nutritional status on outcome in liver transplantation. Transpl Int. 1997;10(5):369-374.
21.
KaidoTMoriAOikeF. Impact of pretransplant nutritional status in patients undergoing liver transplantation. Hepatogastroenterology. 2010;57(104):1489-1492.
22.
ShirabeKYoshimatsuMMotomuraT. Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients. Liver Transpl. 2011;17(9):1073-1080.
23.
SinghNPatersonDLGayowskiTWagenerMMMarinoIR. Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl. 2000;6(1):54-61.
24.
IidaTKaidoTYagiS. Posttransplant bacteremia in adult living donor liver transplant recipients. Liver Transpl. 2010;16(12):1379-1385.
25.
KimSIKimYJJunYH. Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients. Yonsei Med J. 2009;50(1):112-121.
26.
McCulloughAJBugianesiE. Protein-calorie malnutrition and the etiology of cirrhosis. Am J Gastroenterol. 1997;92(5):734-738.
27.
CheungKLeeSSRamanM. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol. 2012;10(2):117-125.
28.
Nutritional status in cirrhosis. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. J Hepatol. 1994;21(3):317-325.
29.
ChristouLPappasGFalagasME. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol. 2007;102(7):1510-1517.
30.
KoulaouzidisABhatSSaeedAA. Spontaneous bacterial peritonitis. World J Gastroenterol. 2009;15(9):1042-1049.
31.
CampilloBRichardetJPBoriesPN. Enteral nutrition in severely malnourished and anorectic cirrhotic patients in clinical practice. Gastroenterol Clin Biol. 2005;29(6-7):645-651.
DurninJVWomersleyJ. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;32(1):77-97.
34.
FrisanchoAR. New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am J Clin Nutr. 1984;40(4):808-819.
35.
HasseJStrongSGormanMALiepaG. Subjective global assessment: alternative nutrition-assessment technique for liver-transplant candidates. Nutrition. 1993;9(4):339-343.
36.
DetskyASMcLaughlinJRBakerJP. What is subjective global assessment of nutritional status?JPEN J Parenter Enteral Nutr. 1987;11(1):8-13.
37.
StephensonGRMorettiEWEl-MoalemHClavienPATuttle-NewhallJE. Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation. Transplantation. 2001;72(4):666-670.
38.
GunsarFRaimondoMLJonesS. Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther. 2006;24(4):563-572.
39.
MorganMYMaddenAMSoulsbyCTMorrisRW. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. Hepatology. 2006;44(4):823-835.
40.
Alvares-da-SilvaMRReverbeldaSilveiraT. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition. 2005;21(2):113-117.
41.
Montano-LozaAMeza-JuncoJPradoC. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10(2):166-173.
42.
EnglesbeMJPatelSPHeK. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010;211(2):271-278.
43.
MattoxTWTeasley-StrausburgKM. Overview of biochemical markers used for nutrition support. DICP. 1991;25(3):265-271.
44.
MullerMJLautzHUPlogmannBBurgerMKorberJSchmidtFW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology. 1992;15(5):782-794.
45.
PirlichMSchutzTSpachosT. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology. 2000;32(6):1208-1215.
46.
SmithFRSuskindRThanangkulOLeitzmannCGoodmanDSOlsonRE. Plasma vitamin A, retinol-binding protein and prealbumin concentrations in protein-calorie malnutrition, III: response to varying dietary treatments. Am J Clin Nutr. 1975;28(7):732-738.
47.
YovitaHDjumhanaAAbdurachmanSASaketiJR. Correlation between anthropometrics measurements, prealbumin level and transferin serum with Child-Pugh classification in evaluating nutritional status of liver cirrhosis patient. Acta Med Indones. 2004;36(4):197-201.
48.
BemeurCDesjardinsPButterworthRF. Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure. J Nutr Metab. 2010;2010:489823.
49.
McCluskeySAKarkoutiKWijeysunderaDN. Derivation of a risk index for the prediction of massive blood transfusion in liver transplantation. Liver Transpl. 2006;12(11):1584-1593.
50.
FusaiGDhaliwalPRolandoN. Incidence and risk factors for the development of prolonged and severe intrahepatic cholestasis after liver transplantation. Liver Transpl. 2006;12(11):1626-1633.
51.
PiquetMAOllivierIGloroRCastelHTiengouLEDaoT. Nutritional indices in cirrhotic patients. Nutrition. 2006;22(2):216-217; author reply 218-219.
TsuchiyaMSakaidaIOkamotoMOkitaK. The effect of a late evening snack in patients with liver cirrhosis. Hepatol Res. 2005;31(2):95-103.
54.
MatthewsDRHoskerJPRudenskiASNaylorBATreacherDFTurnerRC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
55.
CatalanoDTrovatoGMMartinesGFRandazzoMTonzusoA. Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study. Liver Int. 2008;28(9):1280-1287.
56.
RigottiPPetersJCTranbergKGFischerJE. Effects of amino acid infusions on liver regeneration after partial hepatectomy in the rat. JPEN J Parenter Enteral Nutr. 1986;10(1):17-20.
57.
FanSTLoCMLaiECChuKMLiuCLWongJ. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med. 1994;331(23):1547-1552.
58.
PlauthMCabreECampilloB. ESPEN guidelines on parenteral nutrition: hepatology. Clin Nutr. 2009;28(4):436-444.
59.
WicksCSomasundaramSBjarnasonI. Comparison of enteral feeding and total parenteral nutrition after liver transplantation. Lancet. 1994;344(8926):837-840.
60.
PlauthMRoskeAERomaniukPRothEZiebigRLochsH. Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration. Gut. 2000;46(6):849-855.
61.
HeymanJKWhitfieldCJBrockKEMcCaughanGWDonaghyAJ. Dietary protein intakes in patients with hepatic encephalopathy and cirrhosis: current practice in NSW and ACT. Med J Aust. 2006;185(10):542-543.
62.
HirschSBunoutDdelaMazaP. Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. JPEN J Parenter Enteral Nutr. 1993;17(2):119-124.
63.
HirschSdelaMazaMPGattasV. Nutritional support in alcoholic cirrhotic patients improves host defenses. J Am Coll Nutr. 1999;18(5):434-441.
64.
MendenhallCLMoritzTERoselleGA. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology. 1993;17(4):564-576.
65.
KearnsPJYoungHGarciaG. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology. 1992;102(1):200-205.
66.
CabreEGonzalez-HuixFAbad-LacruzA. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics: a randomized controlled trial. Gastroenterology. 1990;98(3):715-720.
67.
Le CornuKAMcKiernanFJKapadiaSANeubergerJM. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation. Transplantation. 2000;69(7):1364-1369.
68.
RichterBSchmandraTCGollingMBechsteinWO. Nutritional support after open liver resection: a systematic review. Dig Surg. 2006;23(3):139-145.
69.
ShirabeKMatsumataTShimadaM. A comparison of parenteral hyperalimentation and early enteral feeding regarding systemic immunity after major hepatic resection—the results of a randomized prospective study. Hepatogastroenterology. 1997;44(13):205-209.
70.
MochizukiHTogoSTanakaKEndoIShimadaH. Early enteral nutrition after hepatectomy to prevent postoperative infection. Hepatogastroenterology. 2000;47(35):1407-1410.
71.
AugustDAHuhmannMB. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr. 2009;33(5):472-500.
72.
KaidoTEgawaHTsujiHAshiharaEMaekawaTUemotoS. In-hospital mortality in adult recipients of living donor liver transplantation: experience of 576 consecutive cases at a single center. Liver Transpl. 2009;15(11):1420-1425.
73.
RondanelliMOpizziAAntonielloN. Effect of essential amino acid supplementation on quality of life, amino acid profile and strength in institutionalized elderly patients. Clin Nutr. 2011;30(5):571-577.
MarchesiniGBianchiGMerliM. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology. 2003;124(7):1792-1801.
76.
MoriwakiHShirakiMFukushimaH. Long-term outcome of branched-chain amino acid treatment in patients with liver cirrhosis. Hepatol Res. 2008;38(suppl 1):S102-S106.
77.
NakayaYOkitaKSuzukiK. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition. 2007;23(2):113-120.
78.
KobayashiMIkedaKAraseY. Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus. J Gastroenterol. 2008;43(1):63-70.
79.
HabuDNishiguchiSNakataniS. Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis. Hepatogastroenterology. 2009;56(96):1719-1723.
80.
Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. The San-in Group of Liver Surgery. Br J Surg. 1997;84(11):1525-1531.
81.
MengWCLeungKLHoRLLeungTWLauWY. Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma. Aust N Z J Surg. 1999;69(11):811-815.
82.
PoonRTYuWCFanSTWongJ. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial. Aliment Pharmacol Ther. 2004;19(7):779-788.
83.
TakeshitaSIchikawaTNakaoK. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. Nutr Res. 2009;29(2):89-93.
84.
IshikawaTMichitakaIKamimuraH. Oral branched-chain amino acids administration improves impaired liver dysfunction after radiofrequency ablation therapy for hepatocellular carcinoma. Hepatogastroenterology. 2009;56(94-95):1491-1495.
85.
KurodaHUshioAMiyamotoY. Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: a one-year prospective trial. J Gastroenterol Hepatol. 2010;25(9):1550-1555.
86.
IwasaMMatsumuraKWatanabeY. Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2003;15(7):733-737.
87.
MutoYSatoSWatanabeA. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol. 2005;3(7):705-713.
88.
FukushimaHMiwaYIdaE. Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration. JPEN J Parenter Enteral Nutr. 2003;27(5):315-322.
89.
BianchiGMarzocchiRAgostiniFMarchesiniG. Update on nutritional supplementation with branched-chain amino acids. Curr Opin Clin Nutr Metab Care. 2005;8(1):83-87.
90.
UrataYOkitaKKorenagaKUchidaKYamasakiTSakaidaI. The effect of supplementation with branched-chain amino acids in patients with liver cirrhosis. Hepatol Res. 2007;37(7):510-516.
91.
SuzukiKKagawaKKoizumiKKatayamaHSugawaraM. Effects of late evening snack on diurnal plasma glucose profile in patients with chronic viral liver disease. Hepatol Res. 2010;40(9):887-893.
92.
OkabayashiTNishimoriIYamashitaK. Preoperative oral supplementation with carbohydrate and branched-chain amino acid-enriched nutrient improves insulin resistance in patients undergoing a hepatectomy: a randomized clinical trial using an artificial pancreas. Amino Acids. 2010;38(3):901-907.
93.
OkamotoMSakaidaITsuchiyaMSuzukiCOkitaK. Effect of a late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis. Hepatol Res. 2003;27(1):45-50.
94.
AoyamaKTsuchiyaMMoriK. Effect of a late evening snack on outpatients with liver cirrhosis. Hepatol Res. 2007;37(8):608-614.
95.
SakaidaITsuchiyaMOkamotoMOkitaK. Late evening snack and the change of blood glucose level in patients with liver cirrhosis. Hepatol Res. 2004;30S:67-72.
96.
OkabayashiTIyokiMSugimotoTKobayashiMHanazakiK. Oral supplementation with carbohydrate- and branched-chain amino acid-enriched nutrients improves postoperative quality of life in patients undergoing hepatic resection. Amino Acids. 2011;40(4):1213-1220.
97.
TogoSTanakaKMoriokaD. Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis. Nutrition. 2005;21(4):480-486.
98.
IshikawaYYoshidaHMamadaY. Prospective randomized controlled study of short-term perioperative oral nutrition with branched chain amino acids in patients undergoing liver surgery. Hepatogastroenterology. 2010;57(99-100):583-590.
99.
YoshidaRYagiTSadamoriH. Branched-chain amino acid-enriched nutrients improve nutritional and metabolic abnormalities in the early post-transplant period after living donor liver transplantation [published online September 23, 2011]. J Hepatobiliary Pancreat Sci.
100.
KawamuraEHabuDMorikawaH. A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status. Liver Transpl. 2009;15(7):790-797.
101.
HoffmannKBuchlerMWSchemmerP. Supplementation of amino acids to prevent reperfusion injury after liver surgery and transplantation: where do we stand today?Clin Nutr. 2011;30(2):143-147.
102.
IjichiCMatsumuraTTsujiTEtoY. Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system. Biochem Biophys Res Commun. 2003;303(1):59-64.
103.
MatsumuraTMorinagaYFujitaniSTakehanaKNishitaniSSonakaI. Oral administration of branched-chain amino acids activates the mTOR signal in cirrhotic rat liver. Hepatol Res. 2005;33(1):27-32.
104.
NishitaniSIjichiCTakehanaKFujitaniSSonakaI. Pharmacological activities of branched-chain amino acids: specificity of tissue and signal transduction. Biochem Biophys Res Commun. 2004;313(2):387-389.
105.
NakamuraIOchiaiKImawariM. Phagocytic function of neutrophils of patients with decompensated liver cirrhosis is restored by oral supplementation of branched-chain amino acids. Hepatol Res. 2004;29(4):207-211.
106.
NakamuraIOchiaiKImaiYMoriyasuFImawariM. Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients. Hepatol Res. 2007;37(12):1062-1067.
107.
KakazuEKannoNUenoYShimosegawaT. Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells. J Immunol. 2007;179(10):7137-7146.
108.
KakazuEUenoYKondoY. Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis. Hepatology. 2009;50(6):1936-1945.
109.
TsukishiroTShimizuYHiguchiKWatanabeA. Effect of branched-chain amino acids on the composition and cytolytic activity of liver-associated lymphocytes in rats. J Gastroenterol Hepatol. 2000;15(8):849-859.
110.
GurusamyKSKumarYDavidsonBR. Methods of preventing bacterial sepsis and wound complications for liver transplantation. Cochrane Database Syst Rev. 2008;(4):CD006660.
111.
SugawaraGNaginoMNishioH. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244(5):706-714.
112.
OkabayashiTNishimoriISugimotoT. Effects of branched-chain amino acids: enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23(12):1869-1873.
113.
HasseJMBlueLSLiepaGU. Early enteral nutrition support in patients undergoing liver transplantation. JPEN J Parenter Enteral Nutr. 1995;19(6):437-443.
114.
RayesNSeehoferDHansenS. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002;74(1):123-127.
115.
RayesNSeehoferDTheruvathT. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant. 2005;5(1):125-130.
116.
NickkholghASchneiderHEnckeJBuchlerMWSchmidtJSchemmerP. PROUD: effects of preoperative long-term immunonutrition in patients listed for liver transplantation. Trials. 2007;8:20.
117.
PlankLDMcCallJLGaneEJ. Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy. Clin Nutr. 2005;24(2):288-296.
118.
KaidoTMoriAOguraY. Impact of enteral nutrition using a new immuno-modulating diet after liver transplantation. Hepatogastroenterology. 2010;57(104):1522-1525.
119.
McClaveSAMartindaleRGVanekVW. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ilI patient. JPEN J Parenter Enteral Nutr. 2009;33:277-316.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
